smallpox

smallpox
Name	Smallpox
Caption	TEM micrograph of Variola virus virions
Field	Infectious disease
Symptoms	Fever, Vomiting, Meningeal symptoms, characteristic skin rash
Complications	Scarring, Blindness, Arthritis
Onset	1 to 3 weeks following exposure
Duration	About 4 weeks
Causes	Variola virus (spread between people)
Risks	Face-to-face contact with infected individual
Diagnosis	Based on symptoms, confirmed by PCR
Differential	Chickenpox, Monkeypox, Measles
Prevention	Smallpox vaccine
Treatment	Supportive care, Antivirals (e.g., Tecovirimat)
Prognosis	30% risk of death (for ordinary type)
Frequency	Eradicated (last natural case in 1977)

smallpox was an acute infectious disease caused by the Variola virus, a member of the Poxviridae family and the Orthopoxvirus genus. It was one of the most devastating diseases known to humanity, responsible for hundreds of millions of deaths throughout history before its eradication. The disease was officially declared eradicated in 1980 following a global immunization campaign led by the World Health Organization, making it the first human disease to be eliminated by deliberate effort.

Overview

The disease presented in two main clinical forms: the severe, more common Variola major and the milder Variola minor. Its historical impact is profound, with evidence of infection found in Egyptian mummies and descriptions in ancient texts from India and China. Major outbreaks significantly altered the course of history, contributing to the decline of the Aztec and Inca empires following contact with European explorers. The development of inoculation practices and later the Smallpox vaccine pioneered by Edward Jenner in 1796 marked critical turning points in the fight against the virus.

Etiology and transmission

The causative agent was the Variola virus, a large, double-stranded DNA virus with a complex structure. It was highly specific to humans, with no known animal reservoir, a key factor that enabled its eventual eradication. Transmission occurred primarily through prolonged face-to-face contact via respiratory droplets expelled by an infected person. Less commonly, the virus could spread through direct contact with contaminated bodily fluids or objects like bedclothes. Patients were most contagious from the onset of the enanthem through the first week of the rash, with the risk declining as scabs formed.

Signs and symptoms

Following an incubation period of about 12 to 14 days, the illness began with a severe Prodrome featuring high fever, Malaise, Headache, Back pain, and often Vomiting. This was followed after 2 to 3 days by the characteristic rash, which appeared first on the oral mucosa, pharynx, and face, then spread to the arms, legs, hands, and feet. The lesions progressed uniformly from macules to papules, vesicles, pustules, and finally scabs over a period of approximately two weeks. Severe cases, such as hemorrhagic or flat types, were almost uniformly fatal.

Prevention and vaccination

The primary and ultimately successful method of prevention was vaccination. Edward Jenner's 1796 use of material from Cowpox lesions to induce immunity laid the foundation for modern Vaccinology. The modern vaccine used a live Vaccinia virus, which is immunologically related to but distinct from the variola virus. A successful vaccination, indicated by a characteristic lesion at the inoculation site, provided high-level protection for 3 to 5 years, with diminishing immunity thereafter. Global surveillance and Ring vaccination strategies were critical components of the World Health Organization's eradication campaign.

Treatment and prognosis

No specific treatment was available during the era of endemic smallpox; management was purely supportive, focusing on fluid therapy, prevention of secondary bacterial infections, and alleviation of symptoms. In the post-eradication era, the Antiviral drug Tecovirimat has been developed and stockpiled by agencies like the Centers for Disease Control and Prevention for use in a potential bioterrorism event. The prognosis varied dramatically by clinical type; the case-fatality rate for ordinary Variola major was about 30%, while Variola minor had a mortality rate of less than 1%. Survivors were often left with extensive pitted scars, particularly on the face, and other complications like Blindness from corneal ulceration.

History and eradication

The disease plagued humanity for millennia, with likely origins in prehistoric times. A major turning point was the introduction of Variolation in the Ottoman Empire, a practice later promoted in Europe by Lady Mary Wortley Montagu. The success of Edward Jenner's vaccine led to widespread immunization efforts. In 1959, the World Health Assembly initiated a plan for global eradication, but the intensive effort, led by Donald Henderson, began in earnest in 1967. Through mass vaccination and meticulous surveillance-containment, the last naturally occurring case was diagnosed in Ali Maow Maalin of Somalia in 1977. The world was officially certified free of smallpox by the World Health Organization in 1980, a landmark achievement in global public health.

Category:Infectious diseases Category:Eradicated diseases Category:World Health Organization